CREDIT SUISSE AG/ - ORIC PHARMACEUTICALS INC ownership

ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 77 filers reported holding ORIC PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of ORIC PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$0
-100.0%
17
-99.9%
0.00%
Q1 2022$94,000
-65.2%
17,761
-3.4%
0.00%
Q4 2021$270,000
-20.4%
18,391
+13.8%
0.00%
Q3 2021$339,000
+46.8%
16,167
+23.3%
0.00%
Q2 2021$231,000
-69.2%
13,110
-57.2%
0.00%
Q1 2021$750,000
+3.9%
30,636
+43.7%
0.00%
Q4 2020$722,00021,3220.00%
Other shareholders
ORIC PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 602,272$2,698,0008.92%
Column Group LLC 3,568,181$15,985,0003.40%
Euclidean Capital LLC 747,550$3,349,0002.85%
Invus Financial Advisors, LLC 1,007,575$4,514,0002.72%
SILVERARC CAPITAL MANAGEMENT, LLC 1,082,304$4,849,0001.49%
Monaco Asset Management SAM 364,741$1,634,0000.71%
EcoR1 Capital, LLC 3,418,068$15,313,0000.53%
DAFNA Capital Management LLC 415,926$1,863,0000.51%
Boxer Capital, LLC 1,054,000$4,722,0000.30%
Casdin Capital, LLC 601,515$2,695,0000.23%
View complete list of ORIC PHARMACEUTICALS INC shareholders